New HIV pill study aims to help young children

NCT ID NCT04375800

Recruiting now Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests an HIV medicine called doravirine in children aged 4 weeks to under 12 years who weigh less than 45 kg. The goal is to see how the drug works in their bodies and if it is safe. About 84 children who are either new to treatment or already have the virus under control will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Be Part Yoluntu Centre ( Site 0606)
RECRUITING

Paarl, Western Cape, 7626, South Africa
CEIP - Centro de Estudios en Infectología Pediátrica ( Site 1002)
COMPLETED

Cali, Valle del Cauca Department, 760042, Colombia
Ciensalud Ips S A S ( Site 1001)
RECRUITING

Barranquilla, Atlántico, 080020, Colombia
Clinica Somer ( Site 1003)
RECRUITING

Rionegro, Antioquia, 054040, Colombia
Clinical Centre for Prevention and Control of AIDS ( Site 0504)
COMPLETED

Krasnodar, Krasnodarskiy Kray, 350015, Russia
Emory Children's Center ( Site 0103)
RECRUITING

Atlanta, Georgia, 30322, United States
Empilweni Services and Research Unit ( Site 0604)
COMPLETED

Johannesburg, Gauteng, 2093, South Africa
FARMOVS PTY LTD ( Site 0601)
COMPLETED

Bloemfontein, Free State, 9301, South Africa
FGU Republican Clinical Infectious Hospital of Roszdrav ( Site 0500)
ACTIVE_NOT_RECRUITING

Saint Petersburg, Sankt-Peterburg, 196645, Russia
Faculty of Medicine - Khon Kaen University ( Site 0903)
RECRUITING

Khon Kaen, 40002, Thailand
Family Clinic Research With UBUNTU ( Site 0605)
RECRUITING

Cape Town, Western Cape, 7505, South Africa
Hospital Infantil de Mexico Federico Gomez ( Site 0702)
ACTIVE_NOT_RECRUITING

Mexico City, Mexico City, 06720, Mexico
Infectious Clinical Hospital #2 ( Site 0501)
COMPLETED

Moscow, Moscow, 105275, Russia
Instituto Nacional de Pediatria ( Site 0701)
COMPLETED

Coyoacán, Mexico City, 04530, Mexico
King Edward Hospital ( Site 0600)
RECRUITING

Durban, KwaZulu-Natal, 4001, South Africa
Krasnoyarsk Regional Center for Prevention and Control of AIDS ( Site 0507)
COMPLETED

Krasnoyarsk, Krasnoyarsk Krai, 660049, Russia
Kuzbasskiy Center for the Prevention and Control of AIDS ( Site 0506)
ACTIVE_NOT_RECRUITING

Kemerovo, Kemerovo Oblast, 650056, Russia
Perinatal HIV Research Unit ( Site 0602)
RECRUITING

Johannesburg, Gauteng, 1864, South Africa
Research Institute for Health Sciences ( Site 0902)
RECRUITING

Chiang Mai, 50200, Thailand
Siriraj Hospital ( Site 0901)
RECRUITING

Bangkok, Bangkok, 10700, Thailand
Tsitsikamma Clinical Research Initiative (TCRI) ( Site 0607)
COMPLETED

Plettenberg Bay, Western Cape, 6600, South Africa
Unidad de Atencion Medica e Investigacion en Salud S.C. ( Site 0700)
COMPLETED

Mérida, Yucatán, 97000, Mexico
University of Colorado at Denver ( Site 0108)
COMPLETED

Aurora, Colorado, 80045, United States
Wits Reproductive Health and HIV Institute (WRHI) ( Site 0603)
RECRUITING

Johannesburg, Gauteng, 2001, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.